Article Text

PDF
Endothelial function and inflammation in coronary artery disease
  1. D Tousoulis,
  2. M Charakida,
  3. C Stefanadis
  1. Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece
  1. Correspondence to:
    Dr Dimitris Tousoulis
    Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece; drtousoulis{at}hotmail.com

Abstract

Evidence supports the central role of endothelium and inflammation in all phases of the atherosclerotic process. Clinical studies have shown their prognostic potential for the development of ischaemic events and for adverse outcome after acute coronary syndromes. Reduction in inflammatory levels and improving endothelial function by traditional and novel treatment strategies were associated with a proportional reduction in cardiovascular events. However, randomised controlled trials are required to explore further whether drugs targeting the inflammatory process and endothelial function will constitute a reasonable adjunctive treatment for patients with coronary artery disease.

  • CAD, coronary artery disease
  • CARE, cholesterol and recurrent events
  • CRP, C reactive protein
  • atherosclerosis
  • endothelium
  • inflammation
  • stable angina

Statistics from Altmetric.com

Footnotes

  • Published Online First 13 September 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.